US FDA explains reaccreditation of third party device reviewers; aligns with IMDRF
This article was originally published in Clinica
Executive Summary
The US FDA has issued a draft guideline on new requirements relating to the third party firms that the agency accredits to review medical device submissions, including an obligation for these firms to apply for reaccredition.